| Literature DB >> 2329569 |
B Cavalleri1, M Turconi, G Tamborini, E Occelli, G Cietto, R Pallanza, R Scotti, M Berti, G Romanó, F Parenti.
Abstract
A series of derivatives of rifamycin P, an antibiotic produced by fermentation of a mutant strain of Nocardia mediterranea or by chemical modification of rifamycin S, have been prepared. The structures of these compounds were determined by 1H NMR, IR, UV, and LC/MS. Their in vitro and in vivo antibacterial activities in comparison with rifampicin and two other rifamycins under investigation were evaluated. The derivatives were more active than rifamycin P against Mycobacterium avium complex and other slowly and rapidly growing nontuberculous mycobacteria which frequently cause systemic infection in patients with AIDS. 2'-(Diethylamino)rifamycin P (P/DEA) appears suitable for further investigation.Entities:
Mesh:
Substances:
Year: 1990 PMID: 2329569 DOI: 10.1021/jm00167a029
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446